Skip to main content
Clinical Trials/NCT00576888
NCT00576888
Completed
Not Applicable

International Registry for Vascular Anomalies Associated With Coagulopathy

Medical College of Wisconsin1 site in 1 country30 target enrollmentNovember 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multifocal Lymphangioendotheliomatosis With Thrombocytopenia
Sponsor
Medical College of Wisconsin
Enrollment
30
Locations
1
Primary Endpoint
Number of patients with genetic mutations, copy number variations and/or expression analysis
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

PURPOSE The purpose of this study is to learn more about multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). MLT is a rare vascular disorder characterized by multiple congenital skin and visceral lesions, profound thrombocytopenia, and gastrointestinal bleeding. The skin lesions may appear red, brown or blue, often misdiagnosed as hemangiomas. The gastrointestinal tract, liver, and lungs are the most common internal organs involved. The severe thrombocytopenia (low platelets) is believed to be the result of platelet trapping within the skin and visceral vascular lesions. Severe and chronic gastrointestinal bleeding is common during infancy and early childhood. Although a relatively newly described entity, MLT was likely previously reported as hemangiomas, blue rubber bleb nevus syndrome, diffuse hemangiomatosis, Kasabach-Merritt phenomenon, and hereditary hemorrhagic telangiectasia. The term cutaneovisceral angiomatosis with thrombocytopenia is also a term used for this same disease. This study is a longitudinal cohort study of MLT to collect detailed clinical data on the distribution of disease, disease severity, and complications. This data will be used to create diagnostic criteria and an evaluation protocol for infants with this disease

Detailed Description

After informed consent is obtained a detailed question will be mailed to participating patients and families. This questionnaire will also be available electronically through an educational website. Data collected will include photographs of skin lesions, video images of gastrointestinal lesions, demographic data, clinical information, therapeutic interventions, glass slides of tissue biopsies, and collection of DNA. Enrollment will be patient family driven and modeled after several successful registries of rare diseases.

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
April 5, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Beth A Drolet, MD

Professor of Dermatology and Pediatrics

Medical College of Wisconsin

Eligibility Criteria

Inclusion Criteria

  • Subjects with a vascular anomaly with coagulopathy

Exclusion Criteria

  • Subjects without a vascular anomaly with coagulopathy

Outcomes

Primary Outcomes

Number of patients with genetic mutations, copy number variations and/or expression analysis

Time Frame: After DNA collected and batches are sent for analysis

Expand knowledge on consensus diagnostic criteria, atypical presentations and long term outcomes of patients with vascular anomalies

Study Sites (1)

Loading locations...

Similar Trials